Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

NCT06809712 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Disease

Interventions

DRUG: Busulfan (Busulfex)
DRUG: Cyclophosphamide (CTX)
DRUG: Fludarabine (Fludara)
DRUG: Semustine (MeccNU)

Sponsor

He Huang